重组菌体疫苗对牛肉毒中毒的保护效力
本研究用大肠杆菌(Escherichia coli)细胞系统生产甲醛灭活的重组菌体疫苗,以小鼠中和试验测定牛体内抗BoNT/C和D的中和抗体滴度,分别为7.45 ± 1.77和6.6 ± 1.28 IU/mL,符合巴西立法保护标准;与纯化重组疫苗相比无显著统计学差异。商业疫苗组抗C和D滴度分别为1.33和3.33 IU/mL。该疫苗安全有效,为牛肉毒中毒预防提供了一种产业友好的替代方案。
要点
- 重组大肠杆菌菌体疫苗诱导牛抗BoNT/C和D中和滴度分别为7.45 ± 1.77和6.6 ± 1.28 IU/mL。
- 该滴度被巴西立法认定为具有保护性。
- 与纯化重组疫苗相比,抗体水平无显著统计学差异。
核心结论
- 重组大肠杆菌菌体疫苗安全有效,能诱导保护性抗体,是预防牛肉毒中毒的产业友好替代方案。
研究设计与样本
- 本研究用大肠杆菌细胞系统生产甲醛灭活的重组蛋白疫苗,并以小鼠中和试验测定牛体内中和抗体滴度。
主要发现
- 甲醛灭活大肠杆菌疫苗诱导牛抗BoNT/C和D的中和平均滴度分别为7.45 ± 1.77和6.6 ± 1.28 IU/mL。
- 该滴度被巴西立法认定为具有保护性。
- 与纯化重组疫苗相比,抗BoNT/C和D抗体水平无显著统计学差异。
- 商业疫苗接种牛后抗BoNT/C和D的中和平均滴度分别为1.33和3.33 IU/mL。
临床怎么用
- 作者认为该重组大肠杆菌菌体疫苗是预防牛肉毒中毒的产业友好替代方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Botulism is a paralytic disease caused by the intoxication of neurotoxins produced by Clostridium botulinum. Among the seven immunologically distinct serotypes of neurotoxins (BoNTs A - G), serotypes C and D, or a chimeric fusion termed C/D or D/C, are responsible for animal botulism. The most effective way to prevent botulism in cattle is through vaccination; however, the commercially available vaccines produced by detoxification of native neurotoxins are time-consuming and hazardous. To overcome these drawbacks, a non-toxic recombinant vaccine was developed as an alternative. In this study, the recombinant protein vaccine was produced using an Escherichia coli cell-based system. The formaldehyde-inactivated E. coli is able to induce 7.45 ± 1.77 and 6.6 ± 1.28 IU/mL neutralizing mean titers against BoNTs C and D in cattle, respectively, determined by mouse neutralization bioassay, and was deemed protective by the Brazilian legislation. Moreover, when the levels of anti-BoNT/C and D were compared with those achieved by the recombinant purified vaccines, no significant statistical difference was observed. Cattle vaccinated with the commercial vaccine developed 1.33 and 3.33 IU/mL neutralizing mean titers against BoNT serotypes C and D, respectively. To the best of our knowledge, this study is the first report on recombinant E. coli bacterin vaccine against botulism. The vaccine was safe and effective in generating protective antibodies and, thus, represents an industry-friendly alternative for the prevention of cattle botulism.
引用
- Moreira C, Ferreira MRA, Finger PF, et al. Protective efficacy of recombinant bacterin vaccine against botulism in cattle. Vaccine. 2020. PMID: 32037222. doi:10.1016/j.vaccine.2020.01.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。